All CRS Reports
R47224

Abortion Law After Dobbs: Federal and State Legal Landscape

Federal & State Law Editorial TeamLast reviewed: April 2026
Jon O. ShimabukuroAugust 20, 2025
abortionreproductive rightsdobbsstate law

Summary

This report examines the legal landscape for abortion regulation following the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization (2022), which overturned Roe v. Wade and returned abortion regulation to the states. It provides an overview of state abortion laws enacted or triggered after Dobbs.

The report discusses federal legal issues, including the application of the Emergency Medical Treatment and Labor Act (EMTALA) to emergency abortion care, the regulation of medication abortion through the FDA, and the Comstock Act's potential application to the mailing of abortion-related materials.

Congressional considerations include proposals to codify or restrict abortion rights at the federal level, conscience protection legislation, federal funding restrictions under the Hyde Amendment, and interstate commerce issues related to abortion travel and telemedicine.

Full Report Analysis

Key Findings

The Supreme Court's decision in Dobbs v. Jackson Women's Health Organization (2022) overturned Roe v. Wade and Planned Parenthood v. Casey, eliminating the constitutional right to abortion and returning authority to regulate abortion to the states.
As of 2025, 14 states have enacted near-total bans on abortion (with limited exceptions), 7 states ban abortion after approximately 6-12 weeks of pregnancy, and approximately 20 states and DC have enacted laws protecting or expanding abortion access.
Medication abortion, using mifepristone and misoprostol, accounted for over 63% of all abortions in the United States in 2023, making the regulation of medication abortion a central policy and legal battleground.
The Hyde Amendment, which has been renewed annually through appropriations since 1976, prohibits the use of federal Medicaid funds for abortion except in cases of rape, incest, or life endangerment.

Background

For nearly 50 years, Roe v. Wade (1973) and Planned Parenthood v. Casey (1992) established a constitutional framework for abortion rights under the Fourteenth Amendment's Due Process Clause. Roe recognized a right to abortion grounded in privacy, while Casey replaced Roe's trimester framework with an "undue burden" standard under which states could regulate abortion so long as regulations did not impose a substantial obstacle to obtaining an abortion before viability. During this period, states enacted hundreds of regulations including waiting periods, informed consent requirements, parental involvement laws, and facility regulations.

The Dobbs decision in June 2022 fundamentally altered this landscape, holding that the Constitution does not confer a right to abortion and that the authority to regulate abortion returns to "the people and their elected representatives." The decision triggered a series of pre-existing "trigger laws" designed to ban abortion immediately upon the reversal of Roe, while other states moved to protect or codify abortion access. The resulting legal landscape varies dramatically by state, creating significant interstate disparities in access to abortion services.

Current Law

Federal law intersects with abortion regulation in several key areas. The Hyde Amendment restricts federal funding of abortion through Medicaid and other federal health programs. The Emergency Medical Treatment and Labor Act (EMTALA) requires hospitals with emergency departments to provide stabilizing treatment for emergency medical conditions, which the Biden administration interpreted to include emergency abortion care even in states with abortion bans. The Supreme Court heard arguments on this interpretation in Moyle v. United States (2024), returning the case to the lower courts without resolving the underlying question.

The Comstock Act (18 U.S.C. Section 1461), a 19th-century statute prohibiting the mailing of "obscene" materials, has been invoked in debates over whether it prohibits the mailing of abortion-related drugs or materials. The FDA regulates mifepristone under a Risk Evaluation and Mitigation Strategy (REMS), and legal challenges to the FDA's approval and loosened distribution requirements reached the Supreme Court in FDA v. Alliance for Hippocratic Medicine (2024), where the Court dismissed the challenge on standing grounds without addressing the merits.

Policy Options

Federal legislative proposals include bills to codify a right to abortion nationwide (the Women's Health Protection Act), bills to impose a national abortion ban after a specified gestational age, legislation to protect interstate travel for abortion services, bills addressing the application of the Comstock Act to abortion medications, and proposals to overturn or modify the Hyde Amendment to allow federal funding of abortion services.

States continue to serve as the primary arena for abortion policy, with legislative and ballot initiative activity across the political spectrum. Policy considerations include the legal treatment of out-of-state abortion travel, the regulation of telehealth prescribing of abortion medications, the enforcement of state abortion laws against healthcare providers, the impact of abortion restrictions on maternal health outcomes and healthcare workforce availability, and the application of conscience protections for healthcare providers who object to performing abortions.

Recent Developments

Abortion has become a defining issue in state and federal elections, with ballot measures protecting abortion access succeeding in multiple states including Ohio, Michigan, California, Vermont, and Kansas. Ongoing litigation continues to shape the post-Dobbs landscape, including cases involving EMTALA preemption, medication abortion regulation, and the scope of state abortion ban exceptions. Data indicate that the number of abortions nationally has not declined substantially post-Dobbs, as increased access in some states, expanded telehealth prescribing, and interstate travel have partially offset reductions in states with bans.

Note: This is a summary of a Congressional Research Service report. CRS reports are prepared for Members of Congress and their staffs. This summary is provided for informational purposes and does not constitute legal advice.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.